Marjory Charlot1,2,3, Jacob Newton Stein1,4, Emily Damone5, Isabella Wood6, Moriah Forster7, Stephanie Baker3,8, Marc Emerson2,5, Cleo Samuel-Ryals2,3,9, Christina Yongue3,10, Eugenia Eng2,3,4, Matthew Manning3,11, Allison Deal2, Samuel Cykert2,3,6. 1. Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC. 2. University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC. 3. Greensboro Health Disparities Collaborative, Greensboro, NC. 4. Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 5. Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 6. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 7. Department of Internal Medicine, University of North Carolina, Chapel Hill, NC. 8. Department of Public Health Studies, Elon University, Elon, NC. 9. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 10. Department of Public Health Education, University of North Carolina at Greensboro, Greensboro, NC. 11. Cone Health Cancer Center, Greensboro, NC.
Abstract
PURPOSE: Timely lung cancer surgery is a metric of high-quality cancer care and improves survival for early-stage non-small-cell lung cancer. Historically, Black patients experience longer delays to surgery than White patients and have lower survival rates. Antiracism interventions have shown benefits in reducing racial disparities in lung cancer treatment. METHODS: We conducted a secondary analysis of Accountability for Cancer Care through Undoing Racism and Equity, an antiracism prospective pragmatic trial, at five cancer centers to assess the impact on overall timeliness of lung cancer surgery and racial disparities in timely surgery. The intervention consisted of (1) a real-time warning system to identify unmet care milestones, (2) race-specific feedback on lung cancer treatment rates, and (3) patient navigation. The primary outcome was surgery within 8 weeks of diagnosis. Risk ratios (RRs) and 95% CIs were estimated using log-binomial regression and adjusted for clinical and demographic factors. RESULTS: A total of 2,363 patients with stage I and II non-small-cell lung cancer were included in the analyses: intervention (n = 263), retrospective control (n = 1,798), and concurrent control (n = 302). 87.1% of Black patients and 85.4% of White patients in the intervention group (P = .13) received surgery within 8 weeks of diagnosis compared with 58.7% of Black patients and 75.0% of White patients in the retrospective group (P < .01) and 64.9% of Black patients and 73.2% of White patients (P = .29) in the concurrent group. Black patients in the intervention group were more likely to receive timely surgery than Black patients in the retrospective group (RR 1.43; 95% CI, 1.26 to 1.64). White patients in the intervention group also had timelier surgery than White patients in the retrospective group (RR 1.10; 95% CI, 1.02 to 1.18). CONCLUSION: Accountability for Cancer Care through Undoing Racism and Equity is associated with timelier lung cancer surgery and reduction of the racial gap in timely surgery.
PURPOSE: Timely lung cancer surgery is a metric of high-quality cancer care and improves survival for early-stage non-small-cell lung cancer. Historically, Black patients experience longer delays to surgery than White patients and have lower survival rates. Antiracism interventions have shown benefits in reducing racial disparities in lung cancer treatment. METHODS: We conducted a secondary analysis of Accountability for Cancer Care through Undoing Racism and Equity, an antiracism prospective pragmatic trial, at five cancer centers to assess the impact on overall timeliness of lung cancer surgery and racial disparities in timely surgery. The intervention consisted of (1) a real-time warning system to identify unmet care milestones, (2) race-specific feedback on lung cancer treatment rates, and (3) patient navigation. The primary outcome was surgery within 8 weeks of diagnosis. Risk ratios (RRs) and 95% CIs were estimated using log-binomial regression and adjusted for clinical and demographic factors. RESULTS: A total of 2,363 patients with stage I and II non-small-cell lung cancer were included in the analyses: intervention (n = 263), retrospective control (n = 1,798), and concurrent control (n = 302). 87.1% of Black patients and 85.4% of White patients in the intervention group (P = .13) received surgery within 8 weeks of diagnosis compared with 58.7% of Black patients and 75.0% of White patients in the retrospective group (P < .01) and 64.9% of Black patients and 73.2% of White patients (P = .29) in the concurrent group. Black patients in the intervention group were more likely to receive timely surgery than Black patients in the retrospective group (RR 1.43; 95% CI, 1.26 to 1.64). White patients in the intervention group also had timelier surgery than White patients in the retrospective group (RR 1.10; 95% CI, 1.02 to 1.18). CONCLUSION: Accountability for Cancer Care through Undoing Racism and Equity is associated with timelier lung cancer surgery and reduction of the racial gap in timely surgery.
Authors: Tanya Agurs-Collins; Susan Persky; Electra D Paskett; Shari L Barkin; Helen I Meissner; Tonja R Nansel; Sonia S Arteaga; Xinzhi Zhang; Rina Das; Tilda Farhat Journal: Am J Public Health Date: 2019-01 Impact factor: 9.308
Authors: Daniel R Gomez; Kai-Ping Liao; Stephen G Swisher; George R Blumenschein; Jeremy J Erasmus; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith Journal: Radiother Oncol Date: 2015-05-23 Impact factor: 6.280
Authors: Regina M Vidaver; Marianna B Shershneva; Scott J Hetzel; Timothy R Holden; Toby C Campbell Journal: J Oncol Pract Date: 2016-05-03 Impact factor: 3.840
Authors: Samuel Cykert; Eugenia Eng; Matthew A Manning; Linda B Robertson; Dwight E Heron; Nora S Jones; Jennifer C Schaal; Alexandra Lightfoot; Haibo Zhou; Christina Yongue; Ziya Gizlice Journal: J Natl Med Assoc Date: 2019-03-28 Impact factor: 1.798